Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications

André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (25)

  1. A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers. 2025-09-01 · Expand citations
  2. Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives. 2025-06-18 · Expand citations
  3. IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain. 2025-05-01 · Expand citations
  4. Refractory CRPS pain treated with psilocybin: A case report. 2024-09-01 · Expand citations
  5. Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial. 2024-05-15 · Expand citations
  6. Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study. 2024-01-01 · Expand citations
  7. Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study. 2024-01-01 · Expand citations
  8. Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain. 2023-12-18 · Expand citations
  9. Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs. 2023-08-01 · Expand citations
  10. Microdosing psilocybin for chronic pain: a case series. 2023-04-01 · Expand citations
  11. Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. 2022-11-11 · Expand citations
  12. The Therapeutic Potential of Psilocybin. 2021-05-15 · Expand citations
  13. Dose-response relationships of psilocybin-induced subjective experiences in humans. 2021-04-01 · Expand citations
  14. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? 2018-05-01 · Expand citations
  15. Clinical potential of psilocybin as a treatment for mental health conditions. 2017-01-01 · Expand citations
  16. OpenAlex W2017462460
  17. OpenAlex W2082947525
  18. OpenAlex W2903001666
  19. OpenAlex W3023228010
  20. OpenAlex W3118615836
  21. OpenAlex W3165837403
  22. OpenAlex W4402748917
  23. OpenAlex W4408581056
  24. OpenAlex W4409704666
  25. OpenAlex W4412080495

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.